• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER Back to Search Results
Catalog Number 70-6529
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/07/2014
Event Type  malfunction  
Manufacturer Narrative
Related to 1218996-2018-00022, user facility called (b)(4) product support team to report discrepant patient results.A pediatric patient was ran on the leadcare ii blood lead testing system and gave a result of 3.3g/dl.When this same patient was sent to a reference lab for a venous confirmatory test the result was 8.0g/dl.The customer's leadcare ii blood lead test kit was returned to magellan for evaluation.During investigative testing, no abnormal results were recorded.It should be noted during the investigation, visual inspection of the returned leadcare ii analyzer confirmed corrosion on the sensor pins.Corrosion of the sensor pins occurs when there is overexposure of the analyzer pins to the assay's acidic treatment reagent.This occurs when used test sensors are not removed immediately after testing (per instrument instructions) or when too much sample is added to the test sensor.Periodic testing with blood lead qc controls is used to monitor analyzer performance.(b)(4) provided the customer with a new instrument, and additional training.No reported harm or injuries occurred as a result of this issue.(b)(4).
 
Event Description
User facility called (b)(4) product support team to report discrepant patient results.A pediatric patient tested on the leadcare ii blood lead testing system and gave a result of 3.3g/dl.When this same patient was sent to a reference lab for a venous confirmatory test the result was 8.0g/dl.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADCARE II BLOOD LEAD TEST SYSTEM
Type of Device
LEADCARE II ANALYZER
Manufacturer (Section D)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave
building 4
n. billerica MA 01862
Manufacturer (Section G)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave
building 4
n. billerica MA 01862
Manufacturer Contact
heather reed
101 billerica ave.
building 4
n. billerica, MA 01862
9782484811
MDR Report Key8027030
MDR Text Key126383566
Report Number1218996-2018-00023
Device Sequence Number1
Product Code DOF
UDI-Device Identifier00850355006017
UDI-Public00850355006017
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/31/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number70-6529
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/29/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/07/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/22/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-